SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, citing stronger demand for Amtagvi and Proleukin, is driving the rally and analyst upgrades. Traders are broadly bullish, with some attributing momentum to possible short covering, while others flag overbought conditions and profit-taking; upcoming lung-cancer data is viewed as a further catalyst but remains pending.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings steep selloff has traders focused on competition from Kalshi and Polymarket and concern that heavier spending to build its own prediction-market business could pressure margins. Bears see the new platforms as a threat to sportsbook economics, while bulls point to growing DKeX activity and legal setbacks for competitors; frustration over the share-price slide and management is widespread.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energys rally is drawing attention to its role in supplying power for AI data centers, with traders citing reassurance that Oracle remains committed to the Project Jupiter fuel-cell deal after force-majeure concerns. Bulls see renewed momentum and possible short covering, while skeptics point to the stocks valuation and risk of a pullback after its sharp swings.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

A new change-of-control severance policy for AST SpaceMobile executives has fueled buyout and strategic-partnership speculation, but traders note the filing is not evidence that a deal is underway. The chatter has accompanied volatile trading and skepticism over the lack of concrete shipment or launch timing for the next BlueBird satellites.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDBs investor-day discussion is focused on Atlas growth guidance, an expanded buyback, and AI product launches, against the backdrop of the CEOs abrupt departure to Meta. Traders are split between optimism about the business outlook and concern that the leadership transition adds uncertainty, with some viewing the sharp selloff as an overreaction.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop next-generation 10 kV silicon-carbide devices sparked a sharp rally, but the move faded. Bulls view the award as technology and domestic-manufacturing validation with potential defense and AI-power applications, while skeptics point to its prototype scope and undisclosed financial terms as reasons near-term revenue impact is unclear.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

The FHFAs move to put VantageScore alongside FICO on Fannie Mae and Freddie Macs mortgage pricing grid is raising concerns that competition could erode FICOs long-standing mortgage-scoring advantage. Traders are debating whether the steep selloff reflects lasting damage to its moat or an overreaction, with bearish calls and dip-buying interest both prominent.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras collaboration with Gimlet Labs to bring its wafer-scale AI systems to Gimlet Cloud is drawing attention as a potential customer-diversification and inference-growth signal. Bullish traders view the deal as validation of demand, while others point to upcoming share unlocks and volatile trading as potential pressure on the stock.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Reported takeover interest from Lundbeck has fueled buyout speculation, although Xeris says it is not for sale and no deal is confirmed. Traders are divided between viewing the report as the start of potential bidding and expecting the denial to dampen momentum.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQures shares are under pressure after four-year AMT-130 data for Huntingtons disease showed less slowing on the cUHDRS measure than at three years, without statistical significance, prompting concerns about the treatments durability. Bulls call the selloff an overreaction, arguing the BLA is based on the stronger three-year data and questioning the four-year comparison; others see the weaker longer-term result as a serious risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MACE BoD of MACE International: 
 
Denis J. Amato - retired from Ancora Advisors, currently Director of Microcap Equities 
 
His investment experience spans five decades, including serving as Chief Investment Officer for a major Cleveland bank trust department as well as with Ancora Advisors. He has both a BBA in Economics and an MBA in Finance from Case Western Reserve University and is a Chartered Financial Analyst. 
 
And yet, with all of that experience, investments he&#39;s involved in tend to steadily go down the longer one holds them.  
 
But something tells me he&#39;s only grown wealthier over that period of time. How could that be? Anyone care to offer an explanation?

bren

Goose Egg

StockTwits Web

Mace Security International Inc.

 BoD of MACE International: 
 
Denis J. Amato - retired from Ancora Advisors, currently Director of Microcap Equities 
 
His investment experience spans five decades, including serving as Chief Investment Officer for a major Cleveland bank trust department as well as with Ancora Advisors. He has both a BBA in Economics and an MBA in Finance from Case Western Reserve University and is a Chartered Financial Analyst. 
 
And yet, with all of that experience, investments he's involved in tend to steadily go down the longer one holds them.  
 
But something tells me he's only grown wealthier over that period of time. How could that be? Anyone care to offer an explanation?